In Australia, virtually all transmitting devices used in close proximity to the human body must comply with EMR Standard 2003 and the ACA EMR Labeling Notice. They must be evaluated against the SAR or reference-level exposure limits of the ARPANSA standard in accordance with the ACA SAR measurement method or by measurements conducted in accordance with AS/NZS 2772.2. MPTE operating within 20 cm of the body and meeting the SAR evaluation criteria must be tested for compliance against the ARPANSA aware- or unaware-user SAR limit. The new regulatory arrangements allow manufacturers flexibility in choosing a method for SAR evaluation of MPTE destined for Australian markets. By using accredited testing, the self-declaration approval path ensures rapid time to market. Suppliers in Australia must ensure that evidence of fulfillment of administrative requirements and the prescribed documentation are available for examination by an ACA auditor.
展开▼
